- Home
- PWOD vs TLSI Comparison
PWOD vs TLSI Comparison
Compare PWOD & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PWOD
- TLSI
- Stock Information
- Founded
- PWOD 1934
- TLSI 2010
- Country
- PWOD United States
- TLSI United States
- Employees
- PWOD N/A
- TLSI N/A
- Industry
- PWOD Major Banks
- TLSI Medical Specialities
- Sector
- PWOD Finance
- TLSI Health Care
- Exchange
- PWOD Nasdaq
- TLSI Nasdaq
- Market Cap
- PWOD 227.1M
- TLSI 124.9M
- IPO Year
- PWOD N/A
- TLSI N/A
- Fundamental
- Price
- PWOD $29.93
- TLSI $4.69
- Analyst Decision
- PWOD
- TLSI Strong Buy
- Analyst Count
- PWOD 0
- TLSI 6
- Target Price
- PWOD N/A
- TLSI $11.75
- AVG Volume (30 Days)
- PWOD 25.1K
- TLSI 36.4K
- Earning Date
- PWOD 01-27-2025
- TLSI 11-14-2024
- Dividend Yield
- PWOD 4.32%
- TLSI N/A
- EPS Growth
- PWOD 20.90
- TLSI N/A
- EPS
- PWOD 2.62
- TLSI N/A
- Revenue
- PWOD $67,724,000.00
- TLSI $26,891,000.00
- Revenue This Year
- PWOD N/A
- TLSI $60.96
- Revenue Next Year
- PWOD N/A
- TLSI $53.65
- P/E Ratio
- PWOD $11.18
- TLSI N/A
- Revenue Growth
- PWOD 5.88
- TLSI 67.90
- 52 Week Low
- PWOD $17.01
- TLSI $3.50
- 52 Week High
- PWOD $34.56
- TLSI $10.42
- Technical
- Relative Strength Index (RSI)
- PWOD 45.65
- TLSI 51.68
- Support Level
- PWOD $28.69
- TLSI $4.72
- Resistance Level
- PWOD $30.99
- TLSI $5.32
- Average True Range (ATR)
- PWOD 0.78
- TLSI 0.31
- MACD
- PWOD -0.20
- TLSI 0.01
- Stochastic Oscillator
- PWOD 37.46
- TLSI 47.52
About PWOD Penns Woods Bancorp Inc.
Penns Woods Bancorp Inc is the bank holding company for Jersey Shore State Bank and Luzerne Bank. The banks serve customers in North Central and North Eastern Pennsylvania through their retail banking, commercial banking, mortgage services and financial services divisions. The Banks are engaged in commercial and retail banking which includes the acceptance of time, savings, and demand deposits, the funding of commercial, consumer, and mortgage loans, and safe deposit services. Utilizing a branch office network, ATMs, Internet, and telephone banking delivery channels, the Banks deliver their products and services to the communities residing in.
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.